Loading...

TC BIOPHARM (HOLDINGS) PLC Management Changes 8-K Filing

TC B

TC BIOPHARM (HOLDINGS) PLC

()

2024 8-K

Show Summary

Summary

AGM Results Summary

Annual Meeting Notice

Shareholder Meeting Update

General Meeting Notice

Nasdaq Delisting Notice

ADS Ratio Change

Special Dividend Announcement

Nasdaq Delisting Notice

Special Dividend Approved

Shareholder Meeting Results

Share Offering Agreement

Shareholder Meeting Notice

Financial Filing Update

Management Compensation Cha...

New Securities Offering

Regained Compliance

Equity Offering Completed

ADS Ratio Change

Nasdaq Compliance Update

Annual Meeting Results

Home Country Exemption

Notice of Delisting or Fail...

Compliance with Minimum Sto...

Agreement with Existing War...

Acquisition of Assets

Shareholder Meeting

Equity Issuance

Departure of CEO and Compen...

Options Grant and Cancellation

Shareholder Update and Prox...

External Links:

TC Biopharm (Holdings) PLC announced the departure of its CEO, Bryan Kobel, who agreed to defer payment of pension benefits and convert a portion into ordinary shares. The board also approved a grant of options to Mr. Kobel.

AI Assistant

TC BIOPHARM (HOLDINGS) PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.